SB 239063 is a selective p38 MAPK inhibitor (IC50 = 44 nM for recombinant purified p38α).{30980} It displays greater than 220-fold selectivity for p38 MAPK over ERK, JNK1, and other kinases.{30980} SB 239063 has been shown to reduce inflammatory cytokin
库存:
1 mg, 5 mg, 500 µg
供应商:
Cayman
CAS号:
193551-21-2
规格:
This biochemical is available in the following size(s) 10 mg, 5 mg, 500 µg - Please inquire
A selective p38 MAP kinase inhibitor (IC50 = 44 nM for p38α) that has been shown to reduce inflammatory cytokine production and is neuroprotective following oral administration in vivo